MERIDIAN CO., LTD.
Korea Head Office: 4Fl., Heungsung BLDG. 197-3, Jamsil-dong, Songpa-Gu, Seoul, Korea
USA Office: 11075 Knott Ave. Cypress, California, USA 90630
Canadian Office: Suite 306 – 2150 West Broadway, Vancouver, BC Canada V6K 4L9
Website (North America): meridianmedical.ca

February 9, 2005 NASD OTC-BB: MRDAF

12th Annual Vancouver Financial Forum – February 11 – 13, 2005
Vancouver Trade & Convention Center - Booth 614

Meridian Co., Ltd. ("Meridian" or the “Company”) (OTC BB: MRDAF), is pleased to announce that the Company will be attending the 12th Annual Vancouver Financial Forum where the financial services industry comes together face-to-face with investors. Some of the most respected financial speakers in the world are featured, while exhibits showcase leading investment products and services.

There is no other place in Canada that you can attend this many seminars and workshops conducted over four days, by some of the most respected financial speakers in the industry in one place. Meridian is excited to have the opportunity to present its company vision and superior product line to the participants of the show. Last year 3,200 people attended the Vancouver show and it’s expected that this year will bring 4,000 people.

Meet Matt Cooke of the Vancouver Canucks!

Matt Cooke will be present at Meridian’s booth #614 to sign autographs between the following hours:

Friday, February 11th: 12:00 pm - 2:00 pm
Saturday, February 12th: 12:00 pm - 2:00 pm
Sunday February 13th: 10 am – 12:00 pm

Anyone who receives a test on Meridian’s Digital Pulse Analyzer (“DPA”) will be eligible not only for an autograph but will be entered to win an official signed “# 24” Vancouver Canucks jersey. The DPA is a quick, non-invasive device that provides early detection of potential cardiovascular dysfunction.

Matt is a strong believer in taking a proactive approach to health. Even well-tuned athletes are not precluded from cardiovascular related illness. Given that Matt has a family history of cardiovascular disease, prevention and awareness are key to remaining in top form.

More About: Digital Pulse Analyzer (“DPA”)

The DPA is an FDA approved device that is inexpensive, non-invasive, and can provide results in minutes. Accumulating evidence suggests that abnormalities in the pulsatile characteristics of arteries occur early in the disease process associated with increased cardiovascular risk, and can be favorably modified by therapeutic interventions.

The Company feels that use of the “DPA” can help caregivers reduce cardiovascular disease in their patient populations through early detection and prevention, and ultimately assist to decrease the associated financial costs placed on the health care industry. Cardiovascular disease is the #1 killer in the United States with an estimated economic cost of approximately $298 billion.

More About: Meridian

Meridian is an established leader in the research/development, manufacturing, and sales of integrative medical diagnostic equipment. The company sells its products and equipment to a wide array of customers in the global health care industry. The company presently holds a total of 18 worldwide patents on its technology, and has received FDA, as well as other international regulatory approvals for many of its products.

Meridian is committed to the ongoing global research and advancement of integrative medical products that contribute to the better health of humanity.

For further information please contact:
Greg Worobec
Corporate Communications
1-877-738-8119